FDA Approved: PHYTONADIONE — Original Application (Cipla USA., Inc.)

View source ↗

Summary

The FDA approved Cipla USA, Inc.'s phytonadione (vitamin K1) under an original application, establishing a generic option for vitamin K supplementation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulopathy
• Hemorrhagic Disease of the Newborn
• Vitamin Deficiency
• Vitamin Deficiency Bleeding

Drugs mentioned

• PHYTONADIONE (phytonadione)

Snippet

ORIG AP for PHYTONADIONE (PHYTONADIONE)